Response to 17-alpha hydroxyprogesterone caproate

被引：0
|
作者：
Frappaolo, Anna [1 ]
Vadnais, Mary [1 ]
机构：
[1] Harvard Vanguard Med Associates, Dept Maternal Fetal Med, Boston, MA 02215 USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2018年 / 219卷 / 02期
关键词：
D O I：
10.1016/j.ajog.2018.04.024
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：217 / 217
页数：1
相关论文
共 50 条
  • [21] Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth
    Yee, Lynn M.
    Liu, Lilly Y.
    Sakowicz, Allie
    Bolden, Janelle R.
    Miller, Emily S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (03)
  • [22] Regarding 'Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth'
    Deng, Zhuo
    Lu, Dan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 270 : 246 - 246
  • [23] Recurrent spontaneous preterm birth risk is not associated with 17-alpha hydroxyprogesterone caproate levels
    Downes, Katheryne L.
    Venkataramanan, Raman
    Caritis, Steve
    Elovitz, Michal A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : S422 - S423
  • [24] SMFM Statement: Use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm birth
    不详
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 223 (01) : B16 - B18
  • [25] Does 17-alpha Hydroxyprogesterone Caproate Prevent Recurrent Preterm Birth in Obese Women?
    Eke, Ahizechukwu C.
    OBSTETRICS AND GYNECOLOGY, 2016, 128 (02): : 403 - 404
  • [26] The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies
    Gyamfi, Cynthia
    Horton, Amanda L.
    Momirova, Valerija
    Rouse, Dwight J.
    Caritis, Steve N.
    Peaceman, Alan M.
    Sciscione, Anthony
    Meis, Paul J.
    Spong, Catherine Y.
    Dombrowski, Mitchell
    Sibai, Baha
    Varner, Michael W.
    Iams, Jay D.
    Mercer, Brian M.
    Carpenter, Marshall W.
    Lo, Julie
    Ramin, Susan M.
    O'Sullivan, Mary Jo
    Miodovnik, Menachem
    Conway, Deborah
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (04) : 392.e1 - 392.e5
  • [27] Does 17-alpha hydroxyprogesterone caproate prevent recurrent preterm birth in obese women?
    Heyborne, Kent D.
    Allshouse, Amanda A.
    Carey, J. Christopher
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 213 (06) : 844.e1 - 844.e6
  • [28] The effect of 17-alpha hydroxyprogesterone caproate (17P) on the midtrimester, proinflammatory milieu of the human cervix
    Wilczek, Renata
    Schubert, Frank
    Hoppensteadt, Debra
    Gianopoulos, John
    Besinger, Richard
    Cunanan, Josephine
    Mittendorf, Robert
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 206 (01) : S235 - S235
  • [29] Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth: a case-control study
    Manuck, T. A.
    Watkins, W. S.
    Esplin, M. S.
    Biggio, J.
    Bukowski, R.
    Parry, S.
    Zhan, H.
    Huang, H.
    Andrews, W.
    Saade, G.
    Sadovsky, Y.
    Reddy, U. M.
    Ilekis, J.
    Yandell, M.
    Varner, M. W.
    Jorde, L. B.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 125 (03) : 343 - 350
  • [30] 17-alpha hydroxyprogesterone caproate decreases mitochondrial respiration in human myometrial cells stimulated with oxytocin
    Onslow, Mitchell L.
    Atasi, Lamia K.
    Stamatkin, Christopher W.
    Patil, Avinash S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (01) : S195 - S195
12345